Home / Drug shortages / Lidocaine Hydrochloride Injection

Lidocaine Hydrochloride Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Lidocaine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 06/13/2018.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0143-9594-25
Dosage Form
Injection
Presentation
Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)
Initial Posting
06/13/2018
Revised Date

FDA data resources